Transradial approach for coronary chronic total occlusion interventions: Insights from a contemporary multicenter

Khaldoon Alaswad1, Rohan V Menon2, Georgios Christopoulos2

  • 1Henry Ford Hospital, Detroit, Michigan.

Insights

Transradial access for chronic total occlusion (CTO) percutaneous coronary interventions (PCI) offers similar success and complication rates compared to transfemoral access. However, transradial PCI involves longer procedure and fluoroscopy times.

Area of Science:

  • Cardiovascular Interventions
  • Interventional Cardiology
  • Vascular Access Techniques

Background:

  • Limited research exists on the safety and effectiveness of transradial access in chronic total occlusion (CTO) percutaneous coronary interventions (PCI).
  • Transradial access is an alternative to transfemoral access for PCI procedures.

Purpose of the Study:

  • To evaluate the impact of transradial access on procedural outcomes in patients undergoing CTO PCI.
  • To compare transradial and transfemoral access techniques for CTO PCI.

Main Methods:

  • A comparative study of 650 CTO PCI cases performed between January 2012 and March 2014 at six US centers.
  • Analysis of procedural success, complication rates, procedure time, fluoroscopy time, and approach changes between transradial and transfemoral access groups.

Main Results:

  • Transradial access was utilized in 17% of cases, with various combinations of radial and femoral access employed.
  • Technical success (92.6% vs. 93.0%) and procedural success (91.1% vs. 90.0%) rates were similar between transradial and transfemoral groups.
  • Major complication rates were comparable (1.7% vs. 1.8%), but transradial access was associated with longer mean procedure (142 vs. 120 min) and fluoroscopy times (58 vs. 49 min).

Conclusions:

  • Transradial CTO PCI is a viable option with comparable success and complication rates to transfemoral CTO PCI.
  • The transradial approach for CTO PCI requires longer procedural and fluoroscopy times.
  • Further research may explore strategies to optimize efficiency for transradial CTO PCI.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
626
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
435
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
499
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
455